Page 7 - First Horizon Advisors Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First horizon advisors inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Horizon Advisors Inc Today - Breaking & Trending Today

Seven Eight Capital LP Acquires New Shares in Hess Midstream LP (NYSE:HESM)

Seven Eight Capital LP bought a new position in shares of Hess Midstream LP (NYSE:HESM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 51,591 shares of the company’s stock, valued at approximately $1,632,000. Several other institutional investors also […] ....

United States , Dekabank Deutsche Girozentrale , Peapack Gladstone Financial Corp , Catalyst Capital Advisors , Wells Fargo Company , First Horizon Advisors Inc , Securities Exchange Commission , Jpmorgan Chase Co , Seven Eight Capital , Hess Midstream , Free Report , Gladstone Financial Corp , Capital Advisors , Horizon Advisors , Get Free Report , Director Infrastructure Investor Global , Visit Holdingschannel , Hess Midstream Daily ,

PPL Co. (NYSE:PPL) Holdings Raised by Gabelli Funds LLC

Gabelli Funds LLC boosted its stake in shares of PPL Co. (NYSE:PPL – Free Report) by 1.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 577,632 shares of the utilities provider’s stock after buying an additional 6,040 shares during the period. […] ....

Rhode Island , United States , Deutsche Bank , Wells Fargo Company , Gabelli Funds , Morgan Stanley , First Horizon Advisors Inc , Investment Management , Exchange Commission , Free Report , Horizon Advisors , Sector Pension Investment Board , Get Free Report , Kentucky Regulated , Pennsylvania Regulated , Visit Holdingschannel ,

Christopher Gibson Sells 50,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of Recursion Pharmaceuticals stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total value of $421,000.00. Following the completion of the transaction, the chief executive officer now directly owns 758,738 […] ....

Christopher Gibson , Securities Exchange Commission , Advisor Group , Recursion Pharmaceuticals Inc , Needham Company , Recursion Pharmaceuticals , First Horizon Advisors Inc , Recursion Pharmaceuticals Stock Performance , Capital Management Inc , Quarter For Recursion Pharmaceuticals , Recursion Pharmaceuticals Company Profile , News Ratings For Recursion Pharmaceuticals Daily , Benjaminf Edwards Company Inc , Institutional Investors Weigh In On Recursion Pharmaceuticals , National Bank , Get Free Report , Exchange Commission , Horizon Advisors , Recursion Pharmaceuticals Daily ,

Epoch Investment Partners Inc. Purchases 374,280 Shares of Shutterstock, Inc. (NYSE:SSTK)

Epoch Investment Partners Inc. boosted its position in shares of Shutterstock, Inc. (NYSE:SSTK – Free Report) by 250.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 523,733 shares of the business services provider’s stock after purchasing an additional 374,280 shares during the quarter. Epoch […] ....

United States , Jarrod Yahes , John Caine , Capital Advisors Inc , Needham Company , Covestor Ltd , Shutterstock Inc , First Horizon Advisors Inc , Third Bancorp , Epoch Investment Partners Inc , Fifth Third Bancorp , Securities Exchange Commission , Morgan Stanley , Nisa Investment Advisors , Exchange Commission , Epoch Investment Partners , Free Report , Investment Partners , Horizon Advisors , Investment Advisors , Stock Down , Get Free Report , North America , Shutterstock Daily ,

Epoch Investment Partners Inc. Purchases 831,199 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Epoch Investment Partners Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 250.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,163,033 shares of the biopharmaceutical company’s stock after buying an additional 831,199 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Halozyme Therapeutics were worth $42,986,000 […] ....

United States , Piper Sandler , Michaelj Labarre , Headlands Technologies , Parkside Financial Bank , Halozyme Therapeutics Inc , Principal Securities Inc , Holdings Channel , Epoch Investment Partners Inc , Quadrant Capital Group , First Horizon Advisors Inc , Wells Fargo Company , Epoch Investment Partners , Halozyme Therapeutics , Free Report , Investment Partners , Horizon Advisors , Financial Bank , Capital Group , Therapeutics Trading Down , Get Free Report , Visit Holdingschannel , Halozyme Therapeutics Daily ,